Skip to content

Clinical trials

Phase 2 Wound Infection trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wound Infection Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20082
20101
20111
20121
20131
20141
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cumberland Pharmaceuticals2
Washington University School of Medicine2
Affinium Pharmaceuticals, Ltd1
Cellceutix Corporation1
Forest Laboratories1
Furiex Pharmaceuticals, Inc1
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.1
RWJ Barnabas Health at Jersey City Medical Center1
Vomaris Innovations1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wound Infection11
Cellulitis6
Abscess5
Bacterial Infections3
Gram-Positive Bacterial Infections3
Burns2
Ulcer2
Diabetic Foot1
Endometritis1
Erysipelas1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.